Mesoblast

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Mesoblast and other ETFs, options, and stocks.

About MESO

Mesoblast Ltd. is a biopharmaceutical company, which engages in the research, development, and market of mesenchymal lineage adult stem cell technology platform. Its medicines target cardiovascular diseases, spine orthopedic disorders, oncology and hematology, immune-mediated, and inflammatory diseases. 

CEO
Silviu Itescu
CEOSilviu Itescu
Employees
81
Employees81
Headquarters
Melbourne, Victoria (VIC)
HeadquartersMelbourne, Victoria (VIC)
Founded
2004
Founded2004
Employees
81
Employees81

MESO Key Statistics

Market cap
2.42B
Market cap2.42B
Price-Earnings ratio
-22.11
Price-Earnings ratio-22.11
Dividend yield
Dividend yield
Average volume
182.60K
Average volume182.60K
High today
$19.21
High today$19.21
Low today
$18.48
Low today$18.48
Open price
$19.19
Open price$19.19
Volume
119.15K
Volume119.15K
52 Week high
$21.50
52 Week high$21.50
52 Week low
$9.61
52 Week low$9.61

Analyst ratings

100%

of 6 ratings
Buy
100%
Hold
0%
Sell
0%

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.